Application

Used for studies of pharmacological activity including: Synergism with fluconazole against Saccharomyces cerevisiae and Candida albicans Efficacy of combination with simeticone on abdominal pain associated with irritable bowel syndrome Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis Drug effects viewed from a signal transduction network perspective Enhanced cytotoxic effect of proteasome inhibitor MG132 Mechanism of action on phasic smooth muscles

Caution

Please find SDS provided by EDQM here..

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Packaging

Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.